SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,746.63 651.99
( 0.83%)

Global Indices

Nasdaq

52,497.89 268.83
(0.51%)

Dow Jones

7,510.69 52.06
(0.70%)

Hang Seng

64,316.33 2,448.90
(3.96%)

Nikkei 225

10,879.26 -18.01
(-0.17%)

Forex

USD-INR

95.59 -0.10
(-0.11%)

EUR-INR

109.79 0.65
(0.59%)

GBP-INR

128.11 0.75
(0.59%)

JPY-INR

0.59 0.01
(1.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Jenburkt Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524731

INE354A01013

446.4761063

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

12.64

475.27

EPS(TTM)

Face Value()

Div & Yield %

85.23

1.92

Back

srs ltd

Shriram Finance consolidated net profit rises 59.89% in the June 2026 quarter

Jul 24,2026

Net profit of Shriram Finance rose 59.89% to Rs 3452.77 crore in the quarter ended June 2026 as against Rs 2159.40 crore during the previous quarter ended June 2025. Sales rose 15.96% to Rs 13229.11 crore in the quarter ended June 2026 as against Rs 11408.20 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	13229.11	11408.20	16
OPM %	75.55	74.28	-
PBDT	4808.51	3079.34	56
PBT	4625.72	2906.23	59
NP	3452.77	2159.40	60

78,746.63 651.99 ( 0.83%)

52,497.89 268.83 (0.51%)

7,510.69 52.06 (0.70%)

64,316.33 2,448.90 (3.96%)

10,879.26 -18.01 (-0.17%)

95.59 -0.10 (-0.11%)

109.79 0.65 (0.59%)

128.11 0.75 (0.59%)

0.59 0.01 (1.09%)